×
results found in ( seconds)
Code
Description

ICD-10-CM Code Z51.11
Encounter for antineoplastic chemotherapy

BILLABLE
Billable Code
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.
POA Exempt
POA Exempt Code
The Center for Medicare & Medicaid Services (CMS) requires medical coders to indicate whether or not a condition was present at the time of admission, in order to properly assign MS-DRG codes. This "Present On Admission" (POA) indicator is recorded on CMS form 4010A.
| ICD-10 from 2011 - 2016

Z51.11 is a billable ICD code used to specify a diagnosis of encounter for antineoplastic chemotherapy. A 'billable code' is detailed enough to be used to specify a medical diagnosis.

POA Indicators on CMS form 4010A are as follows:

IndicatorMeaningCMS Will Pay CC/MCC DRG Costs
YDiagnosis was present at time of inpatient admissionYes
NDiagnosis was not present at time of inpatient admissionNo
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.No
WClinically undetermined. Provider unable to clinically determine whether the condition was present at the time of inpatient admission.Yes
1Exempt from POA reportingNo


MS-DRG Mapping

  • DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with major operating room procedure with MCC.
  • DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with major operating room procedure with CC.
  • DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with major operating room procedure without CC or MCC.
  • DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with other operating room procedure with CC or MCC.
  • DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with other operating room procedure without CC or MCC.
  • DRG Group #837-839 - Chemo with acute leukemia as sdx or with high dose chemo agent with MCC.
  • DRG Group #837-839 - Chemo with acute leukemia as sdx with CC or high dose chemo agent.
  • DRG Group #837-839 - Chemo with acute leukemia as sdx without CC or MCC.
  • DRG Group #846-848 - Chemotherapy without acute leukemia as secondary diagnosis with MCC.
  • DRG Group #846-848 - Chemotherapy without acute leukemia as secondary diagnosis with CC.
  • DRG Group #846-848 - Chemotherapy without acute leukemia as secondary diagnosis without CC or MCC.

ICD-10-CM Alphabetical Index References for 'Z51.11 - Encounter for antineoplastic chemotherapy'

The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code Z51.11. Click on any term below to browse the alphabetical index.

Equivalent ICD-9 Code GENERAL EQUIVALENCE MAPPINGS (GEM)

Encounter for antineoplastic chemotherapy (exact match)

This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code V58.11 was previously used, Z51.11 is the appropriate modern ICD10 code.


Parent Code: Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy

** This Document Provided By ICD.Codes **
Source: http://icd.codes/icd10cm/Z5111